International Journal of Gynecologic Cancer: 34 (8)

Lead Article

Mirvetuximab soravtansine in folate receptor alpha (FRα)–high platinum-resistant ovarian cancer: final overall survival and post hoc sequence of therapy subgroup results from the SORAYA trial (10 June, 2024)
Robert L Coleman, Domenica Lorusso, Ana Oaknin, Sabrina Chiara Cecere, Hannelore Denys, Nicoletta Colombo, Toon van Gorp, Jason A Konner, Margarita Romeo Marin, Philipp Harter, Conleth Murphy, Yuemei Wang, Brooke Esteves, Michael Method, Ursula Matulonis

Editorial

Antibody–drug conjugate targeting folate receptor α: a new milestone in personalized medicine for high-grade serous ovarian cancer (11 July, 2024) Free
Antonio Gonzalez-Martin

Consensus statement

The International Gynecologic Cancer Society consensus statement on palliative care (23 June, 2024)
Keiichi Fujiwara, Stephen R Connor, Noriko Fujiwara, Raimundo Correa, Anisa Mburu, Debbie Leopold, Mary Eiken, Michael Loran Pearl

Vulvar Cancer

Role of V-Y flap reconstruction in vulvar cancer patients: multicenter retrospective study (13 July, 2024)
Violante Di Donato, Andrea Giannini, Valerio Galli, Mariano Catello Di Donna, Mario Antonio Congiu, Giorgia Garganese, Francesco Plotti, Flavia Sorbi, Tullio Golia D'Augè, Antonio Simone Laganà, Stefano Gentileschi, Anna Amelia Caretto, Ilaria Cuccu, Francesca Falcone, Mario Malzoni, Enzo Ricciardi, Giorgia Perniola, Camilla Turetta, Helmut Plett, Massimiliano Fambrini, Vito Chiantera, Enrico Vizza, Roberto Angioli, Francesco Raspagliesi, Ludovico Muzii, Giovanni Scambia, Pierluigi Benedetti Panici, Giorgio Bogani

Cervical Cancer

A non-comparative, randomized, phase II trial of atezolizumab or atezolizumab plus tiragolumab for programmed death-ligand 1-positive recurrent cervical cancer (SKYSCRAPER-04) (10 June, 2024) Free
Ritu Salani, Mary McCormack, Yong-Man Kim, Sharad Ghamande, Shaundra L Hall, Domenica Lorusso, Lisa Barraclough, Lucy Gilbert, Adrian Guzman Ramirez, Chien-Hsing Lu, Renaud Sabatier, Nicoletta Colombo, Youyou Hu, Venkatesh Krishnan, Luciana Molinero, Yuning Feng, Nicole Kim, Marcela Castro, Yvonne G Lin, Bradley J Monk
Adjuvant external beam radiotherapy combined with brachytherapy for intermediate-risk cervical cancer (25 June, 2024) Free
Nuria Agusti, David Viveros-Carreño, Alexander Melamed, Rene Pareja, Alexa Kanbergs, Chi-Fang Wu, Roni Nitecki, Lauren Colbert, Jose Alejandro Rauh-Hain
Cervical cancer and risk of dementia: real-world insights from a nationwide cohort study in Taiwan (23 July, 2024)
Siou-Ting Lee, Yi-Liang Lee, Chi-Hsiang Chung, Wu-Chien Chien, Sung-Tao Li, Chia-Yi Yao, Nian-Sheng Tzeng

Uterine Cancer

DNA methylation detection is a significant biomarker for screening endometrial cancer in premenopausal women with abnormal uterine bleeding (23 July, 2024)
Xingping Zhao, Yanfei Yang, Yinqin Fu, Weigang Lv, Dabao Xu
Endometrial cancer with positive sentinel lymph nodes: pathologic characteristics of metastases as predictors of extent of lymphatic dissemination and prognosis (23 April, 2024)
Giorgia Dinoi, Khaled Ghoniem, Yajue Huang, Valentina Zanfagnin, Giuseppe Cucinella, Carrie Langstraat, Gretchen Glaser, Amanika Kumar, Amy Weaver, Michaela McGree, Francesco Fanfani, Giovanni Scambia, Andrea Mariani
Integrated histological parameters define prognostically relevant groups in atypical endometrial hyperplasia/endometrioid intraepithelial neoplasia (6 May, 2024)
Antonio Raffone, Luigi Insabato, Diego Raimondo, Irene Del Piano, Marialuisa Ricciardiello, Pasquale Cretella, Daniele Neola, Damiano Arciuolo, Angela Santoro, Renato Seracchioli, Maurizio Guida, Antonio Travaglino, Gian Franco Zannoni
Predictive value of SUVmax from initial 18F-FDG PET/CT scans for treatment outcomes in endometrial cancer patients undergoing fertility sparing management (16 May, 2024)
Ok-Ju Kang, Yonghee Park, Eun Min Lee, Jong Jin Lee, Shin-Wha Lee, Dae-Yeon Kim, Dae-Shik Suh, Jong-Hyeok Kim, Yong-Man Kim, Jeong-Yeol Park
Pegylated liposomal doxorubicin combined with trabectedin as a treatment option in uterine sarcomas: a single-institution retrospective analysis (30 April, 2024)
Magdalena Steinlechner, Laura Strobel, Katharina Leitner, Teresa L Pan, Barin Feroz, Christian Marth, Alain G Zeimet
Low-dose lenvatinib and anti-programmed cell death protein-1 combination therapy in patients with heavily pre-treated recurrent ovarian and endometrial cancer: a pilot study (24 April, 2024)
Xiao Shang, Hao Su, Xin Chen, Yutong Wang, Xirun Wan, Ying Zhang, Ying Jin, Fengzhi Feng
Molecular classification of endometrial carcinoma on endometrial biopsy: an early prognostic value to guide personalized treatment (1 July, 2024) Free
Stefano Restaino, Alice Poli, Martina Arcieri, Laura Mariuzzi, Maria Orsaria, Angelica Tulisso, Giulia Pellecchia, Federico Paparcura, Marco Petrillo, Giorgio Bogani, Stefano Cianci, Vito Andrea Capozzi, Anna Biasioli, Alessandro Buda, Jessica Mauro, Francesco Fanfani, Anna Fagotti, Lorenza Driul, Giovanni Scambia, Giuseppe Vizzielli

Ovarian Cancer

An open-label, single-arm, prospective, multi-center, tandem two-stage designed phase II study to evaluate the efficacy of fulvestrant in women with recurrent/metastatic estrogen receptor-positive gynecological malignancies (FUCHSia study) (9 May, 2024)
Rita Trozzi, Sandra Tuyaerts, Daniela Annibali, Alejandro Herreros Pomares, Lotte Boog, Peter Van Dam, Karin Leunen, Christophe Deroose, Hans Trum, Frédéric Amant
A randomized phase II trial to examine modified vaccinia Ankara-5T4 vaccine in patients with relapsed asymptomatic ovarian cancer (TRIOC) (17 May, 2024)
Agnieszka Michael, William Wilson, Sunny Sunshine, Nicola Annels, Richard Harrop, Daniel Blount, Hardev Pandha, Rosemary Lord, Yen Ngai, Shibani Nicum, Laura Stylianou, Stephen Gwyther, Iain A McNeish, Allan Hackshaw, Jonathan Ledermann
Stereotactic radiotherapy for managing ovarian cancer oligoprogression under poly (ADP-ribose) polymerase inhibitors (PARPi) (31 May, 2024)
Stefano Durante, Francesco Cuccia, Michele Rigo, Giovanni Caminiti, Federico Mastroleo, Roberta Lazzari, Giulia Corrao, Giuseppe Caruso, Sabrina Vigorito, Federica Cattani, Giuseppe Ferrera, Vito Chiantera, Filippo Alongi, Nicoletta Colombo, Barbara Alicja Jereczek-Fossa
Measuring the impact of specific surgical complications after ovarian cancer cytoreductive surgery on short-term outcomes (1 July, 2024)
Arwa Mohammad, Chiara Ainio, Deepa Maheswari Narasimhulu, Michaela McGree, Amy L Weaver, Amanika Kumar, Annalisa Garbi, Andrea Mariani, Giovanni Aletti, Francesco Multinu, Carrie Langstraat, William Cliby
Higher incidence of venous thromboembolism associated with increasing lines of treatment in heavily treated ovarian cancer patients (13 July, 2024)
Erika J Lampert, Jennifer L Hansen, Surabhi Tewari, Meng Yao, Laura M Chambers, Roberto Vargas, Mariam M AlHilli

Survivorship

Obesity paradox: is a high body mass index positively influencing survival outcomes in gynecological cancers? A systematic review and meta-analysis (19 April, 2024)
Matteo Pavone, Marta Goglia, Cristina Taliento, Lise Lecointre, Nicolò Bizzarri, Francesco Fanfani, Anna Fagotti, Giovanni Scambia, Jacques Marescaux, Denis Querleu, Barbara Seeliger, Chérif Akladios

Reviews

Management of endometrial cancer in Latin America: raising the standard of care and optimizing outcomes (2 May, 2024)
Albano Blanco, Angélica Nogueira-Rodrigues, Filomena Marino Carvalho, Gonzalo Giornelli, Mansoor Raza Mirza
Notable surgical trials in gynecologic oncology: a 10-year overview (10 June, 2024) Free
José C Vilches, María Clara Santía, Elise Mann Yates, Rene Pareja, Manuel Lozano, Pedro T Ramirez

Clinical trial

ENGOT-EN20/GOG-3083/XPORT-EC-042 – A phase III, randomized, placebo-controlled, double-blind, multicenter trial of selinexor in maintenance therapy after systemic therapy for patients with p53 wild-type, advanced, or recurrent endometrial carcinoma: rationale, methods, and trial design (16 April, 2024)
Ignace Vergote, Alejandro Perez Fidalgo, Giorgio Valabrega, Bradley J Monk, Thomas Herzog, David Cibula, Nicoletta Colombo, Bhavana Pothuri, Jalid Sehouli, Jacob Korach, Joyce Barlin, Christos A Papadimitriou, Toon van Gorp, Debra Richardson, Michael McCarthy, Yoland Antill, Mansoor Raza Mirza, Kai Li, Pratheek Kalyanapu, Brian Slomovitz, Robert L Coleman

Tumor board

Advanced uterine 'gastric-gastrointestinal' type mucinous adenocarcinoma (5 August, 2024) Free
Elena Olearo, Giulio Fraternali Orcioni, Marinella Destefanis, Luca Donato, Andrea Puppo

Corners of the world

First workshop on cervix cancer surgery in Latin America: a hands-on experience from Lima, Perú (9 April, 2024) Free
Joan Flaubert Perez Villena, Marco Sánchez Salcedo, Absalon Montoya Guivin, Vladimir Villoslada Terrones, Aldo Lopez Blanco

Video articles

How to reduce anterior resection syndrome and post-operative complication after rectosigmoid resection (28 March, 2024) Free
Giulio Ricotta, Elodie Gauroy, Anne-Sophie Navarro, Alejandra Martinez, Gwenael Ferron
Step by step abdominal wall closure in elective midline laparotomy (19 April, 2024) Free
M Reyes Oliver- Perez, Oscar Caso-Maestro, Beatrice Conti-Nuño, Rocio Bermejo, Blanca Gil-Ibañez, Alvaro Tejerizo-Garcia
Tumoral clearance of the right portal hilar area: surprises beyond ‘no visual disease’ (16 April, 2024) Free
Ghanim Khatib, Emine Gulen Kucukbingoz, İrem Hatipoglu, Mehmet Ali Vardar

Pathology archives

Clear cell adenocarcinoma of Müllerian origin in a patient with germline SMARCA4 mutation
(1 December, 2023)
Megan Ahern Sylvester, Amanika Kumar, Farah S Baban, Luigi Antonio De Vitis
Isolated nodal gliomatosis in ovarian immature teratoma (1 December, 2023)
Divya Bansal, Sunil Pasricha, Anila Sharma, Meenakshi Kamboj

Images

Endometrial carcinoma: tibial metastasis as initial presentation (5 August, 2024)
Nadia Veiga Canuto, Juan Carlos Muruzábal Torquemada

Commentary

Operative performance indicators: benchmarking gynecological robotic surgery (14 June, 2024)
Faiza Gaba, Thomas Edward Ind, Marielle Nobbenhuis

Letters

Correspondence on ‘Medicolegal, infrastructural, and financial aspects in gynecologic cancer surgery and their implications in decision making processes: Quo Vadis?’ by Allanson et al (8 June, 2024)
James Nevin, Helen Bolton
Response to: Correspondence on ‘Medicolegal, infrastructural,and financial aspects in gynecologic cancer surgery and their implications in decision making processes: Quo Vadis?’ by Nevin and Bolton (8 June, 2024)
Emma Allanson, Paul A Cohen, Robert Bristow

Main menu

Table of contents

August 2024 - Volume 34 - 8

Lead Article

Editorial

Consensus statement

Vulvar Cancer

Cervical Cancer

Uterine Cancer

Ovarian Cancer

Survivorship

Reviews

Clinical trial

Tumor board

Corners of the world

Video articles

Pathology archives

Images

Commentary

Letters

Issue Information

Log in using your username and password

Main menu

Log in using your username and password

You are here

Table of contents

August 2024 - Volume 34 - 8

Lead Article

Editorial

Consensus statement

Vulvar Cancer

Cervical Cancer

Uterine Cancer

Ovarian Cancer

Survivorship

Reviews

Clinical trial

Tumor board

Corners of the world

Video articles

Pathology archives

Images

Commentary

Letters

Issue Information